Sirt3 Genetically Engineered Apoptotic Bodies Alleviate Skeletal Aging by Limiting Aggravated NLRP3 Inflammasome Activation of Senescent Macrophages
Advanced Science · 2026
DOI: 10.1002/advs.202517554 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Yanglin Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, P. R. China. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Sirtuin 3, Macrophages, Inflammasomes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Innovative Research Group Project of the National Natural Science Foundation of China.
Abstract (Originalsprache)
Skeletal aging is characterized by increased fragility, reduced bone mass, and deterioration of bone microstructure. Although aging‐related immune dysfunction of macrophages, namely immunosenescence, is known to contribute to this process, the underlying mechanism remains poorly understood. Here, we find that the senescence of macrophages leads to a decrease in the expression of Sirtuin3 (Sirt3), which in turn leads to increased basal and lipopolysaccharides (LPS)‐induced protein expression of NLRP3 and facilitates the assembly of NLRP3 inflammasome in macrophages that mediates aging‐related osteoporosis. Given the phagocytic property of macrophages, we develop a genetically engineered apoptotic body‐based platform for targeted delivery of Sirt3 to macrophages and verify that Sirt3‐enriched apoptotic bodies (ABs‐Sirt3) delay skeletal aging by promoting ubiquitination and degradation of NLRP3. Our work reveals that Sirt3 plays a key role in regulating aggravated inflammatory responses that accelerate skeletal aging during macrophage senescence and illustrates a novel nanotechnology‐based therapeutic approach targeting immune senescence‐induced acceleration of skeletal aging, which may provide potential therapeutic value for human patients with age‐related osteoporosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedics, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, P. R. China.
- Department of Orthopaedics, Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases, Shanghai Institute of Traumatology and Orthopaedics, Ruijin Hospital, Shanghai Jiao Tong University School of…
- Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
- Department of Spinal Surgery, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, P. R. China.
ORCID-Profile: Yanglin Wu, Ming Cai
Förderung
- National Natural Science Foundation of China
- Innovative Research Group Project of the National Natural Science Foundation of China
Zitieren
APA
Wu, Y., Ling, S., Mao, J., Wang, H., Wang, B., Che, Z., Cui, W., & Cai, M. (2026). Sirt3 Genetically Engineered Apoptotic Bodies Alleviate Skeletal Aging by Limiting Aggravated NLRP3 Inflammasome Activation of Senescent Macrophages. Advanced Science. https://doi.org/10.1002/advs.202517554
Vancouver
Wu Y, Ling S, Mao J, Wang H, Wang B, Che Z, et al. Sirt3 Genetically Engineered Apoptotic Bodies Alleviate Skeletal Aging by Limiting Aggravated NLRP3 Inflammasome Activation of Senescent Macrophages. Advanced Science. 2026. doi:10.1002/advs.202517554
BibTeX
@article{Wu2026,
author = {Wu, Yanglin and Ling, Shifeng and Mao, Jiayi and Wang, Hongyi and Wang, Bo and Che, Zhenjia and Cui, Wenguo and Cai, Ming},
title = {Sirt3 Genetically Engineered Apoptotic Bodies Alleviate Skeletal Aging by Limiting Aggravated NLRP3 Inflammasome Activation of Senescent Macrophages},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202517554}
}
EUVIMED